These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25302737)

  • 1. Removal of biologic response modifiers associated with platelet transfusion reactions: strategies worth considering?
    Garraud O; Cognasse F; Hamzeh-Cognasse H; Spinelli S; Phipps RP; Blumberg N
    Transfusion; 2014 Oct; 54(10):2583. PubMed ID: 25302737
    [No Abstract]   [Full Text] [Related]  

  • 2. Removal of biological response modifiers associated with platelet transfusion reactions by columns containing adsorption beads.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2014 Jul; 54(7):1790-7. PubMed ID: 24417744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile nonhemolytic transfusion reactions to platelets.
    Heddle NM
    Curr Opin Hematol; 1995 Nov; 2(6):478-83. PubMed ID: 9372039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perils of platelet transfusions.
    Kruskall MS
    N Engl J Med; 1997 Dec; 337(26):1914-5. PubMed ID: 9407160
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of platelet transfusion: past, present and future.
    Katus MC; Szczepiorkowski ZM; Dumont LJ; Dunbar NM
    Vox Sang; 2014 Aug; 107(2):103-13. PubMed ID: 24650183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO incompatible platelets: risks versus benefit.
    Dunbar NM; Ornstein DL; Dumont LJ
    Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory mediators in platelet transfusion reactions.
    Morrell CN
    Hematology Am Soc Hematol Educ Program; 2011; 2011():470-4. PubMed ID: 22160076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cross matching test (including lymphocyte cross matching test, platelet cross matching test)].
    Okuda M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():782-7. PubMed ID: 20942189
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological principles of transfusion of blood platelet and granulocyte concentrates].
    Zupańska B
    Acta Haematol Pol; 1979 Oct; 10(4):327-32. PubMed ID: 539356
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
    Xiao W; Tormey CA; Capetillo A; Maitta RW
    Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-donor platelets reduce the risk of septic platelet transfusion reactions.
    Herman JH; Klumpp TR
    Transfusion; 2002 Apr; 42(4):506-7; author reply 507. PubMed ID: 12076301
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO and platelet transfusion therapy.
    Cooling L
    Immunohematology; 2007; 23(1):20-33. PubMed ID: 17425412
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet storage and adverse transfusion outcomes: old platelets?
    Eder AF; Moroff G
    Transfusion; 2010 Nov; 50(11):2288-91. PubMed ID: 21182627
    [No Abstract]   [Full Text] [Related]  

  • 16. Red cells and platelets. Modifications for special patients.
    Lehman CM; Becker JL; Wilkinson DS
    Clin Lab Med; 1996 Dec; 16(4):781-95. PubMed ID: 8974195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
    Wang RR; Triulzi DJ; Qu L
    Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Substitution of thrombocyte concentrates in polytransfused patients].
    Mempel W; Böck M
    Beitr Infusionsther; 1993; 31():81-5. PubMed ID: 7693269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing platelet transfusions in chronically thrombocytopenic patients.
    Slichter SJ
    Semin Hematol; 1998 Jul; 35(3):269-78. PubMed ID: 9685173
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.